Pharyngeal Diseases
7
1
2
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
14.3%
1 terminated out of 7 trials
66.7%
-19.8% vs benchmark
14%
1 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
Effect of Gum Chewing on Sore Throat After Double-lumen Tube Intubation
Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery
Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19)
The Lolland-Falster Health Study
ENT FiberLase CO2 Study
Study of Changes in Reflux Symptoms and Reflux Finding Score According to Rabeprazole Treatment Period